Acta Med. 2009, 52: 15-18

https://doi.org/10.14712/18059694.2016.101

Mood Stabilizer Therapy and Pravastatin: Higher Risk for Adverse Skin Reactions?

Alice Waldera, Pierre Baumannb

aPsychiatric Hospital Sanatorium Kilchberg, Alte Landstrasse 70–84, CH-8802 Kilchberg, Switzerland
bDepartment of Psychiatry, Vaudois University Hospital Centre (DP-CHUV), Site de Cery, CH-1008 Prilly-Lausanne, Switzerland

Received October 1, 2008
Accepted April 1, 2009

Crossref Cited-by Linking

  • Hahn M., Roll S. C.: Validierung von Interaktionsdatenbanken in der Psychopharmakotherapie. Nervenarzt 2018, 89, 319. <https://doi.org/10.1007/s00115-017-0385-0>
  • Pérez-Pico Ana, Marcos-Tejedor Félix, Iglesias-Sánchez María, Acevedo Raquel: Importance of Footwear for Preventing Xerosis and Hyperkeratosis in Older People with Psychiatric Disorders Living in an Institution. IJERPH 2018, 15, 584. <https://doi.org/10.3390/ijerph15040584>
  • Salna Michael P., Singer Hannah M., Dana Ali N.: Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis. Case Reports in Dermatological Medicine 2017, 2017, 1. <https://doi.org/10.1155/2017/3418204>
Crossref Cited-by Linking logo